3653 results for «313»
3653 results
Is frailty still relevant after 20 years of TAVI?
28 Nov 2022 – From PCR London Valves 2022
Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.
Imaging for mitral valve interventions
28 Nov 2022 – From PCR London Valves 2022
Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.
Valve-in-valve TAVI: Session 2
28 Nov 2022 – From PCR London Valves 2022
Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...
TAVI in complex situations - LIVE case
28 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI with the presence of a mechanical mitral valve.
An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
TAVI in patients at risk of coronary occlusion
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI in patients at risk of coronary occlusion to discover a selection of cases presented during PCR LV 2022: hyperacute obstruction of the left main artery due to calcium displacement during TAVR, cannulation technique for challenging coronary access following TAVI-in-TAVI, complex TAVI from...
Challenging scenarios: TAV-in-TAV procedures
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover some challenging TAV-in-TAV procedures, and learn more about the key role of imaging during pre-procedural work-up and the potential treatment options after TAVI bioprosthetic valve fracture.
Mitral: new devices and procedural refinements
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of cases regarding mitral new devices: transapical mitral valve implantation for treatment of symptomatic mitral valve disease, transcatheter edge-to-edge mitral valve repair for atrial functional mitral regurgitation, and much more!
Secondary mitral regurgitation: challenges in management
28 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.
Bubble trouble: aortic air embolization and de-embolization during coronary angiography
09 Aug 2021
Air embolism (AE) is a rare complication during interventional procedures and one of the most scaring for interventional cardiologists. Air bubbles in the coronary circulation often result in ischemic symptoms, vasospasm, and even cardiac arrest. In addition, arrhythmias are common and closely related to the coronary ...
Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial
29 Oct 2024
Luigi Biasco provides his take on the results of the EARLY TAVR trial, presented by Philippe Genereux at TCT 2024 in Washington.
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
Intravascular ultrasound-guided or angiography-guided complex high-risk PCI – The IVUS CHIP trial
28 Mar 2026
Daniele Giacoppo reports and provides his perspective on the main results of the IVUS-CHIP trial, presented by Roberto Diletti from the Erasmus University Medical Center, Rotterdam, the Netherlands, during a Late-Breaking Trials session at the ACC.26 in New Orleans, and simultaneously published in the New England Journal of...
Author
